Publications While At Healthpartners
Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE Trial
American Journal of Medicine.
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial
Diabetes, Obesity & Metabolism.
Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin
Hypertension (Dallas, Tex..
Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
New England Journal of Medicine.
Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract]
Map of science